At an AHA-sponsored briefing today on Capitol Hill, hospital leaders called for changes in Medicare’s Hospital Readmissions Reduction Program. Michael Langberg, M.D., senior vice president of medical affairs and chief medical officer at Cedars-Sinai in Los Angeles, said hospitals shouldn’t be “penalized for resources and functions they cannot control,” including sociodemographic factors, such as poverty and lack of supportive services in the community. Leaders from Ochsner Health System in New Orleans and Presence Health in Chicago also participated in the briefing. The panelists also urged Congress to support the Establishing Beneficiary Equity in the Hospital Readmission Program Act, S. 688/H.R. 1343. The AHA-supported bill would require the Centers for Medicare & Medicaid Services to account for patient sociodemographic status when making risk adjustments to the readmissions penalties. At the briefing, the AHA also released a new TrendWatch report showing that the national readmission rate is declining, but reducing readmissions is a “complex undertaking because not all readmissions can or should be prevented; indeed, some are planned as part of sound clinical care.”

Blog
h2, h3, h4 {color: #002855;} Postpartum hemorrhage (PPH) is one of the most common — and preventable — causes of maternal health in the United States. The…
Chairperson's File
Public
For decades, hospitals and health systems have used innovation to improve patient care and outcomes. We have seen dramatic improvements and know we can never…
Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…
Chairperson's File
Public
This week, March 8-14, is Patient Safety Awareness Week. Delivering safe, quality care to all patients is the top priority for everyone working in hospitals…
Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…